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Summary Epileptic seizures during infancy have a wide variety of clinical pre-
sentations and the outcome differs according to the etiology. Among the benign and
rare causes of infantile seizures, Vitamin B12 deficiency has been encountered.
Common symptoms of Vitamin B12 deficiency in infants include megaloblastic anemia,
feeding difficulties, developmental delay, microcephaly, failure to thrive, hypotonia,
lethargy, irritability, involuntary movements, seizures and cerebral atrophy. Involun-
tary movements and seizures may rarely be the initial symptoms of Vitamin B12
deficiency. Involuntary movements have also been reported to appear after initiation
of Vitamin B12 supplementation in isolated cases, whereas, no such information exits
for seizures. In this paper, three infants with Vitamin B12 deficiency associated with
motor and mental retardation are reported because of long-lasting focal/multifocal
epileptic seizures following the initiation of intramuscular Vitamin B12 treatment.
Antiepileptics were introduced in addition to Vitamin B12. Seizures disappeared within
a few days or weeks; electroencephalographic findings were normalized in a few
months. No relapses occurred during the follow-up period.
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Epileptic seizures during infancy are often compli-
cated by diagnostic and therapeutic problems.
Although they are less common, the benign andn behalf of British Epilepsy Association.
70 G. Benbir et al.treatable forms possess particular importance,
because prompt diagnosis is mandatory in such con-
ditions, to avoid unnecessary investigations and
possible long-term sequale. Vitamin deficiencies
constitute a major group among those conditions
as they are largely preventable, and potentially
reversible, but may result with serious neurological
problems if not treated properly. Vitamin B12 is
essential, and supplied by diet. Neurological pro-
blems resulting from Vitamin B12 deficiency have
been recognized for many years.1 The commonly
developing symptoms of Vitamin B12 deficiency in
infants include megaloblastic anemia, feeding dif-
ficulties, developmental delay, microcephaly, fail-
ure to thrive, hypotonia, and cerebral atrophy with
symptoms of lethargy, cerebral involvement with
irritability, and rarely seizures.2 Involuntary move-
ments have been reported rarely to appear after the
initiation of treatment with Vitamin B12 injection,
3—
5 but no such information exists in relation to epi-
leptic seizures, as to our knowledge.
Here, we describe three cases with Vitamin B12
deficiency associated by psycho-motor delay in
varying degrees who developed epileptic seizures
during Vitamin B12 replacement therapy. All seizures
and/or the ictal electroencephalographic (EEG)
changes were focal or multifocal, long-lasting, or
continuous in the form of epileptic status.Case reports
Case 1
A 13-months-old male infant was diagnosed as hav-
ing anemia related to Vitamin B12 deficiency, as also,
motor and mental delay. He was referred to our
department when twitchings on his face were
started on the fourth day of the treatment with
100 mg intramuscular Vitamin B12 daily, as they
increased in frequency and became continuous by
time. He was the fourth child of non-consanguineous
parents, born at term. The pregnancy and delivery
were uncomplicated. He was only breast-fed until
admission. Neurological examination revealed gen-
eralized hypotonia with hyperactive deep-tendon
reflexes (DTRs). He was slightly malnourished. He
was 73 cm (3rd percentile) and 9300 g (3rd—10th
percentile), and his head circumference was 45 cm
(3rd—10th percentile). The baby had poor social
interaction, insufficient head control and was
unable to sit without support. He had erratic myo-
clonias on his face and all extremities, even during
sleep.
His initial blood values revealed hemoglobin (Hb)
as 6 g/dL, a mean corpuscular volume (MCV) as 89 fLand Vitamin B12 levels as 60 pg/mL (44.28 pmol/L).
Peripheral blood smear showed anisocytosis and
hypersegmentation of neutrophiles; as the bone
marrow aspirate revealed significant megaloblastic
features. Cranial magnetic resonance imaging (MRI)
showed cerebral atrophy.
An EEG recording was done immediately after
admission. The EEG of the patient in a status of
multifocal erratic myoclonic jerks and a sustained
focal clonic seizure involving the left perioral region
and the arm revealed high-voltage (200—300 mV),
continuous, spike-and-wave activity with a 8—10 Hz
frequency, localized in the right fronto-centro-tem-
poral region. Fast activity with medium voltage was
present on the left hemisphere, intermixed with
some sharp and slow elements on the fronto-tem-
poral region. No discrete discharges associating
erratic myoclonias were visible in the EEG.
Oral clonazepam treatment (0.1 mg/kg/day) was
initiated. Seizures gradually decreased within the
second week and resolved completely at the third
week of treatment. A second EEG 10 days after an
asymptomatic period, however, showed ictal activ-
ity identical to the previous one. No more specific
epileptogenic changes were present in the EEG
recorded 2 months after the cessation of seizures.
Marked improvement in muscle tonus, head control,
and social interaction was apparent at that time.
The patient is being followed by oral clonazepam
and intramuscular Vitamin B12 treatment for about a
year by now. He is seizure-free and developmental
improvement continues.
Case 2
A 13-months-old male infant with mild motor and
mental retardation was diagnosed as having Vitamin
B12 deficiency and a replacement therapy with
intramuscular Vitamin B12 (1 mg twice, weekly)
was started. He was transferred to our unit due
to seizures appearing on the 11th day of treatment.
Seizures were right-sided, with brachio-facial invol-
vement and of clonic type. They lasted for 5—
10 min, and repeated several times a day. The
patient was the fifth child of a non-consanguineous
couple. He was born at term following an uncom-
plicated pregnancy and delivery. He had been only
breast-fed. On admission, he was pale, and had mild
hepatomegaly. He had mild psychomotor delay and
growth retardation with a height at 10th percentile
and a weight between 3rd and 10th percentiles.
Neurological examination revealed mild hypotonia
and hypoactive DTRs. In blood tests, Hb level was
5.2 g/dL, MCV was 104 fL, and he had hypersegmen-
tation of neutrophiles and anisocytosis in peripheral
blood smear. He was found to have low serum
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normal folate levels. His bone marrow aspiration
revealed significant megaloblastic features. Cranial
MRI showed mild cerebral atrophy. EEG recording
during a clinically seizure-free period revealed con-
tinuous spike-and-wave activity with high amplitude
(100—150 mV) and 7—8 Hz frequency, restricted to
the left temporal region. Diffuse, irregular activity
with mixed frequency was apparent in all other
regions. Immediately after starting clonazepam,
seizures disappeared. The patient is seizure-free
since then. Second EEG, 2 months later, showed
random sharp waves in both fronto-central regions,
with left predominance. During his latest examina-
tion at 21st month, he had reached age-appropriate
psychomotor development. The EEG recording
repeated at this time was normal.
Case 3
A 12-months-old female with motor and mental
retardation was brought to our unit due to apathy
for the last few weeks. Investigations revealed
Vitamin B12 deficiency and she was put on intramus-
cular Vitamin B12 treatment (100 mg/day). At the
eighth day of the treatment, she developed some
chewing movements along with clonic jerks on theFigure 1 Ictal and interictal EEG findings of Case 3.left perioral muscles, and alternatingly on either, or
both arms. She was the ninth child of a non-con-
sanguineous couple. All her siblings were healthy.
She was born at term with normal delivery from an
uncomplicated pregnancy. The patient had been
largely breast-fed. She was previously started on
phenobarbitone treatment on one of her earlier
hospital visits due to developmental retardation.
Her parents deny any previous seizures, but were
told that her EEG at that time was ‘abnormal’. On
admission, she was pale, and had mild hepatome-
galy. She was severely malnourished with her height
(66 cms) and weight (6180 g) below 3rd percentile.
She had generalized hypotonia and diminished DTRs.
She could not sit without support.
A complete blood count showed megaloblastic
anemia with Hb level of 5.5 g/dL, and MCV of
107 fL. In peripheral blood smear, anisocytosis, poi-
kilocytosis and hypersegmentation of the leukocytes
were noted. The serum Vitamin B12 level was low as
57.2 pg/mL (42.21 pmol/L), and folate was normal
(13.6 ng/mL). Her bone marrow aspiration revealed
significant megaloblastic features. MRI of the brain
showed delayed myelination and generalized cere-
bral atrophy. Complete blood count and serum B12
level (583 pg/mL; 430.25 pmol/L) of the mother
were normal.Note the ictal discharge on left occipital region.
72 G. Benbir et al.Repeated EEGs during the patient’s stay in
hospital revealed bilateral, diffuse, polyspike-and-
wave discharges with high amplitude (200—300 mV)
with or without interhemispheric symmetry. Ictal
spiking (Fig. 1) localized to the left occipital region
was accompanied by clonic contractions of right arm
and chewing movements. Because of epileptic sta-
tus, oral clonazepam (0.6 mg/day) was added to
phenobarbitone (30 mg/day), but no improvement
was seen. A steady decrease in the seizure fre-
quency took place after valproic acid (80 mg/day)
was added to the treatment. By this combination,
epileptic seizures disappeared within a few days.
The EEG repeated 2 months later showed a definite
improvement.
In her latest control examination, the patient was
2 (4/12) years old, she had no more seizures after
her discharge from the hospital. Her cognitive and
neurological development was normal for her age;
except, there was a mild tremor on both hands. The
control EEG was normal, and cranial MRI showed
improvement in both myelination and atrophic
changes. She is on valproic acid and Vitamin B12
treatment, up to present.
A detailed work-up including serum electrolyte
levels, thyroid function tests, serum folate, iron,
ferritin, biotinidase activity, serum amino acid chro-
matography, acyl carnitine and amino acid profile
with tandem mass chromatography, protein in 24 h
urine, and electrocardiography revealed normal
results in all patients. Unfortunately, Vitamin B12
levels in breast milk nor the tests for intestinal
absorption were not available in our patients and
the etiology of Vitamin B12 deficiency remained
unexplained. However, since nutrition in all three
patients was restricted mainly to mothers’ milk with
no additional support, a dietary deficiency was
suspected as a possible cause for the condition.Discussion
Vitamin B12 deficiency has been shown to be a
benign and rare cause of epileptic seizures, during
infancy.6 Although, this deficiency can be tolerated
by adults for several years through compensation by
the endogenous pool, infants may become sympto-
matic within a few months because of the limited
hepatic reserve.7 Upon administration, increase in
blood Vitamin B12 levels can be detected; however,
the clinical signs need 4—6 months to recover. More-
over, some severe pictures, especially those related
to neurological and cognitive involvement may be
irreversible.2
Infantile Vitamin B12 deficiency was first defined
by Jadhav et al.,8 nutritional Vitamin B12 deficiencywas reported later, most often in infants of vegetar-
ian mothers.9,10 Lundgren and Blennow also pointed
out that Vitamin B12 deficiency could facilitate the
appearance of familial benign seizures.11 On the
other hand, Vitamin B12 therapy was resulted in
arrest of convulsions in an infant with severe epi-
leptic encephalopathy.12 Involuntary movements
and epileptic seizures may infrequently be the
initial symptoms of Vitamin B12 deficiency.
Involuntary movements were observed after the
initiation of Vitamin B12 treatment
3—5; but, no such
report exists about seizures, to our knowledge. In
the present cases, epileptic seizures developed dur-
ing the course of intramuscular treatment with
Vitamin B12. Although, some EEG abnormalities were
reported before the substitution of Vitamin B12 in
the third case, there was no history of seizures until
they became apparent following the initiation of
treatment. There was no familial history of infantile
seizures either, that might have been triggered with
Vitamin B12 deficiency. An additional feature com-
mon for all three cases presented here, was the very
long-lasting focal seizures, in the form of focal or
multifocal motor epileptic status accompanied by
prominent EEG changes. A prompt cessation in sei-
zures took place in one case, and within a few
weeks, in the remaining two. Disappearance of
the epileptogenic changes in the EEGs and normal-
ization of the background activity were achieved
within a few months, in all. It was observed that
epileptic seizures did not show any relapses in the
follow-up periods, and repeated EEGs revealed
normal findings.
The pathogenesis of the neurological complica-
tions in Vitamin B12 deficiency, including myoclonus
and tremor, is not clearly understood. Among dif-
ferent theories proposed, changes in plasma amino
acid concentrations and hyperactivation of the
metabolic pathways containing Vitamin B12 by the
initiation of its treatment following a deficiency
state were mainly considered in the pathogenesis
of involuntary movements.4 Also, pathophysiology
of epileptogenesis due to Vitamin B12 deficiency is
not clarified yet. Homocysteine, a sulphur-contain-
ing amino acid, has been shown to induce seizures in
rats.13—15 A clear anticonvulsant action of glutamate
receptor antagonists against seizures induced by
homocysteine and by homocysteic acid has been
demonstrated.16,17 It has also been suggested that
cerebral neurons with destroyed myelin sheaths
secondary to Vitamin B12 deficiency are more sus-
ceptible to the excitatory effects of glutamate.18
These experimental studies may indicate an epilep-
togenic role of both homocysteine and its metabo-
lite in the pathophysiology of central nervous
system involvement in Vitamin B12 deficiency,
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further studies may be needed for a thorough under-
standing of all the processes involved. The assump-
tion that a transient disequilibrium in the metabolic
pathways caused by initial local deficiency and later
produced excessiveness suggested for the develop-
ment of involuntary movements4 may also be rele-
vant for the pathogenesis of the epileptic seizures
following the initiation of replacement therapy by
Vitamin B12.
Cases reported here, suggest that Vitamin B12
deficiency should be considered in the etiological
diagnosis of neurological symptoms in infants, espe-
cially in the presence of megaloblastic anemia and
developmental delay. As well as during the defi-
ciency state, epileptic seizures, even focal or multi-
focal motor epileptic status, may also be seen after
the initiation of replacement therapy. Early diag-
nosis and treatment is important for Vitamin B12-
deficient children, since the age of onset and the
duration of neurological symptoms may contribute
to the development of irreversible deficits. It is not
clearly evident from the present data whether or
not prophylactic anticonvulsant treatment is
needed after the acute episode subsides. Absence
of seizure recurrence and normalization of the EEG
within a limited timemay be considered as factors in
favor of eliminating long-term prophylaxis. These
data suggest that in conditions where epileptic
seizures may take place at the time of replacement
therapy with Vitamin B12, antiepileptic treatment
may be administered without any interruption in the
replacement procedure, and, both the selection of
the appropriate antiepileptic drug, as also the dura-
tion of the treatment may be decided on an indivi-
dual patient’s basis.References
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